Ambrx Biopharma Inc.·4

Apr 28, 6:00 PM ET

Nelson Sonja 4

4 · Ambrx Biopharma Inc. · Filed Apr 28, 2023

Insider Transaction Report

Form 4
Period: 2023-04-26
Nelson Sonja
Chief Fin. & Operating Officer
Transactions
  • Award

    Ordinary Shares

    2023-04-26+1,000,0001,000,000 total
Footnotes (2)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
  • [F2]Represents grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest as follows: (i) 25% of the RSUs will vest on the six-month anniversary of the grant date of April 26, 2023 (the "Grant Date"), (ii) 25% of the RSUs will vest on the 12-month anniversary of the Grant Date, (iii) 25% of the RSUs will vest on the 24-month anniversary of the Grant Date, and (iv) 25% of the RSUs will vest on the 36-month anniversary of the Grant Date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION